About Oniria Therapeutics
Modulating cell dormancy to overcome cancer persistence
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Undisclosed
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
oniriatherapeutics.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $1,400,000 · Seed
startupintros.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Oniria Therapeutics.
Funding History
Seed equity
· May 11, 2023
$1,400,000 startupintros.com
Founders & Leadership
Carlos Galdeano
Co-Founder and Scientific Advisor in drug discovery
Work email & phone locked
Unlock →
Esther Riambau
Co-Founder and Chief Executive Officer
Work email & phone locked
Unlock →
Héctor G. Palmer
Co-Founder and Chief Scientific Officer
Work email & phone locked
Unlock →
Isabel Puig
Co-Founder and Scientific Advisor for new therapeutic targets
Work email & phone locked
Unlock →
Josep Tabernero
Co-Founder and Clinical Advisor
Work email & phone locked
Unlock →
Xavier Barril
Co-Founder and Scientific Advisor in computational chemistry
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026